Kyverna Therapeutics (KYTX) files $300M mixed shelf

Kyverna Therapeutics (NASDAQ: KYTX) has filed $300,000,000 mixed shelf of:

Common Stock
Preferred Stock
Debt Securities
Warrants
Rights
Units
Depositary Shares

You May Also Be Interested In

• OpenAI: after the Hugging Face incident, we committed to conducting a much broader review of actions taken by our models
• Merck and Daiichi Sankyo withdraw lung cancer drug application
• Genco Shipping amends shareholder rights agreement, extends to 2027